Totally implantable central venous access ports. Analysis of 700 cases

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 654-656

  Barbetakis, Nikolaos ^a   Asteriou, Christos ^a   Kleontas, Athanassios ^a   Tsilikas, Christodoulos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

chemotherapy; complications; device

Indexed keywords

AMIODARONE; ANTINEOPLASTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTERY PUNCTURE; ARTICLE; BACTEREMIA; BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CATHETER RUPTURE; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; DEATH; DEVICE SAFETY; DIGESTIVE SYSTEM CANCER; EMBOLISM; FEMALE; FOLLOW UP; GUIDE WIRE; GYNECOLOGIC CANCER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; IMPLANT; INFECTIOUS COMPLICATION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PINCH OFF SYNDROME; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY ARTERY; RETROSPECTIVE STUDY; SKIN INJURY; THORAX DRAINAGE; TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORT; URINARY TRACT CANCER; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 80053614217     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21990     Document Type: Article

References (12)

1. Biffi R, Pozzi S, Agazzi A, et al.: Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: Results of a monocentre series of 376 patients. Ann Oncol 2004; 15: 296-300. (Pubitemid 38262631)
2. Biffi R, de Braud F, Orsi F, et al.: Totally implantable central venous access ports for long-term chemotherapy. Ann Oncol 1998; 9: 773-776.
3. Broviac JW, Cole JJ, Scribner BH,: A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-606.
4. Hickman RO, Buckner CD, Clift RA, et al.: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875. (Pubitemid 9190337)
5. Carde P, Cosset-Delaigue MF, Laplanche A, et al.: Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: A randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989; 25: 939-944. (Pubitemid 19148697)
6. Wolosker N, Yazbek G, Nishinari K, et al.: Totally implantable venous catheters for chemotherapy: Experience in 500 patients. Sao Paulo Med J 2004; 122: 147-151. (Pubitemid 39545238)
7. Grannan KJ, Taylor PH,: Early and late complications of totally implantable venous access devices. J Surg Oncol 1990; 44: 52-54. (Pubitemid 20162930)
8. Di Carlo I, Pulvirenti E, Mannino M, et al. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann Surg Oncol 2010; 17: 1649-1656.
9. Brothers TE, Von Moll LK, Niederhuber JE, et al.: Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988; 166: 295-301. (Pubitemid 18096802)
10. Pasquale MD, Campbell JM, Magnant CM,: Groshong versus Hickman catheters. Surg Gynecol Obsiel 1992; 174: 408-410.
11. Kappers-Klunne MC, Degener JE, Stijnen T, et al.: Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer 1989; 64: 1747-1752. (Pubitemid 19251150)
12. Sotir MJ, Lewis C, Bisher EW, et al.: Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999; 20: 187-191.